Back to GetFilings.com



Table of Contents

 

U.S. SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

(Mark One)

x   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended May 31, 2003

 

¨   TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Transition Period from                      to                     

 

Commission File Number: 0-11868

 


 

CARDIODYNAMICS INTERNATIONAL CORPORATION

(Exact name of registrant as specified in its charter)

 

California

(State or other jurisdiction of incorporation or organization)

 

95-533362

(IRS Employer Identification No.)

6175 Nancy Ridge Drive, Suite 300, San Diego, California

(Address of principal executive offices)

 

92121

(Zip Code)

 

(858) 535-0202

(Registrant’s telephone number)

 


 

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  x  No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act).  Yes x  No  ¨

 

As of July 10, 2003, 46,200,724 shares of common stock and no shares of preferred stock were outstanding.

 



Table of Contents

CARDIODYNAMICS INTERNATIONAL CORPORATION

 

FORM 10-Q

 

TABLE OF CONTENTS

 

          Page No.

PART I – FINANCIAL INFORMATION     
Item 1.    Financial Statements:     
     Balance Sheets (unaudited) at May 31, 2003 and November 30, 2002.    3
     Statements of Operations (unaudited) for the three and six months ended May 31, 2003 and 2002.    5
     Statements of Cash Flows (unaudited) for the six months ended May 31, 2003 and 2002    6
     Notes to Financial Statements (unaudited).    8
Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operation    12
Item 3.    Quantitative and Qualitative Disclosures about Market Risk    18
Item 4.    Controls and Procedures    18
PART II – OTHER INFORMATION     
Item 1.    Legal Proceedings    20
Item 2.    Changes in Securities    20
Item 3.    Defaults Upon Senior Securities    20
Item 4.    Submission of Matters to a Vote of Security Holders    20
Item 5.    Other Information    20
Item 6.    Exhibits and Reports on Form 8-K    20
     Signatures    21

 

-2-


Table of Contents

PART I – FINANCIAL INFORMATION

 

Item  1.    Financial   Statements

 

CARDIODYNAMICS INTERNATIONAL CORPORATION

 

Balance Sheets

(Unaudited, in thousands, except share data)

     May 31,
2003


   November 30,
2002


Assets

             

Current assets:

             

Cash and cash equivalents

   $ 7,179    $ 6,879

Accounts receivable, net of allowance for doubtful accounts of $2,230 in 2003 and $1,726 in 2002

     7,946      8,349

Inventory, net

     3,494      3,474

Current portion of long-term receivables

     2,487      2,522

Other current assets

     336      222
    

  

Total current assets

     21,442      21,446

Property and equipment, net

     539      414

Long-term receivables and note receivable, net

     1,785      1,654

Other assets

     52      52
    

  

Total assets

   $ 23,818    $ 23,566
    

  

Liabilities and Shareholders’ Equity

             

Current liabilities:

             

Accounts payable

   $ 1,111    $ 1,528

Accrued expenses

     111      173

Accrued salaries, wages and benefits

     1,147      1,195

Income taxes payable

     48     

Current portion of deferred service revenue

     247      285

Current portion of deferred rent

     16      16

Reserve for warranty repairs – current

     18      69

Current portion of capital lease obligations

     16      16
    

  

Total current liabilities

     2,714      3,282
    

  

Long-term portion of deferred service revenue

     133      166

Long-term portion of deferred rent

     101      106

Reserve for warranty repairs – long-term

     440      264

Long-term obligations under capital leases

     11      24
    

  

Total long-term liabilities

     685      560
    

  

Total liabilities

     3,399      3,842

 

Continued

 

-3-


Table of Contents

CARDIODYNAMICS INTERNATIONAL CORPORATION

 

Balance Sheets (Continued)

(Unaudited, in thousands, except share data)

 

     May 31,
2003


    November 30,
2002


 

Commitments and contingencies

   $ —       $ —    

Shareholders’ equity:

                

Preferred stock, 18,000,000 shares authorized, no shares issued or outstanding at May 31, 2003 or November 30, 2002

     —         —    

Common stock, no par value, 100,000,000 shares authorized, issued and outstanding 46,186,787 at May 31, 2003 and 46,171,584 shares at November 30, 2002

     49,832       49,774  

Accumulated other comprehensive income

     6       3  

Accumulated deficit

     (29,419 )     (30,053 )
    


 


Total shareholders’ equity

     20,419       19,724  
    


 


Total liabilities and shareholders’ equity

   $ 23,818     $ 23,566  
    


 


 

See accompanying notes to financial statements.

 

-4-


Table of Contents

CARDIODYNAMICS INTERNATIONAL CORPORATION

 

Statements of Operations

(Unaudited – In thousands, except per share data)

 

    

Three Months Ended

May 31,


   

Six Months Ended

May 31,


 
     2003

    2002

    2003

    2002

 

Net sales

   $ 7,285     $ 5,623     $ 13,670     $ 9,989  

Cost of sales

     1,672       1,560       3,304       2,838  
    


 


 


 


Gross margin

     5,613       4,063       10,366       7,151  
    


 


 


 


Operating expenses:

                                

Research and development

     784       611       1,520       1,253  

Selling and marketing

     3,870       3,049       7,351       5,770  

General and administrative

     479       422       978       861  
    


 


 


 


Total operating expenses

     5,133       4,082       9,849       7,884  
    


 


 


 


Income (loss) from operations

     480       (19 )     517       (733 )
    


 


 


 


Other income (expense):

                                

Interest income

     82       76       175       182  

Interest expense

     (5 )     (3 )     (10 )     (6 )

Other, net

     —         (6 )     —         (25 )
    


 


 


 


Total other income

     77       67       165       151  
    


 


 


 


Income (loss) before provision for income taxes

     557       48       682       (582 )

Provision for income taxes

     (39 )     (1 )     (48 )     (1 )
    


 


 


 


Net income (loss)

   $ 518     $ 47     $ 634     $ (583 )
    


 


 


 


Net income (loss) per common share, basic and diluted

   $ .01     $ .00     $ .01     $ (.01 )
    


 


 


 


Weighted-average number of shares used in per share calculation:

                                

Basic

     46,187       46,114       46,184       46,024  
    


 


 


 


Diluted

     47,104       47,433       47,176       46,024  
    


 


 


 


 

See accompanying notes to financial statements.

 

-5-


Table of Contents

CARDIODYNAMICS INTERNATIONAL CORPORATION

 

Statements of Cash Flows

(Unaudited – In thousands)

 

    

Six Months Ended

May 31,


 
     2003

    2002

 

Cash flows from operating activities:

                

Net income (loss)

   $ 634     $ (583 )

Adjustments to reconcile net income (loss) to net cash provided by (used) in operating activities:

                

Depreciation and amortization

     147       144  

Provision for obsolete inventory

     15       56  

Provision for warranty repairs

     125       78  

Provision for (reduction in) demonstration inventory

     8       (16 )

Provision for doubtful receivables

     504       188  

Provision for doubtful long-term receivables

     13       25  

Compensatory stock options granted

     19       36  

Other non-cash items

     3       —    

Changes in operating assets and liabilities:

                

Accounts receivable

     (101 )     371  

Inventory

     (43 )     (760 )

Other current assets

     (114 )     (240 )

Long-term receivables and note receivable

     (109 )     (24 )

Accounts payable

     (417 )     112  

Accrued expenses

     (62 )     (15 )

Accrued salaries, wages and benefits

     (48 )     (82 )

Income taxes payable

     48       —    

Deferred rent

     (5 )     —    

Deferred service revenue

     (71 )     (10 )
    


 


Net cash provided by (used in) operating activities

     546       (720 )
    


 


Cash flows from investing activities:

                

Purchases of property and equipment

     (272 )     (92 )
    


 


Net cash used in investing activities

     (272 )     (92 )
    


 


 

Continued

 

 

 

 

 

 

 

 

 

 

 

 

See accompanying notes to financial statements.

 

-6-


Table of Contents

CARDIODYNAMICS INTERNATIONAL CORPORATION

 

Statements of Cash Flows (Continued)

(Unaudited – In thousands)

 

     Six Months Ended
May 31,


 
     2003